Rakovina Therapeutics Inc.
RKVTF
$0.10
$0.00-4.61%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -143.45% | -149.50% | -149.36% | -94.28% |
| Total Depreciation and Amortization | -- | -3.01% | -3.15% | -3.15% | -3.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 260.39% | 65.47% | 63.82% | 95.70% |
| Change in Net Operating Assets | -- | -304.93% | -211.50% | -211.50% | -302.19% |
| Cash from Operations | -- | -178.82% | -391.18% | -391.18% | -154.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 228.71% | 304.59% | 304.59% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -226.24% | -82.43% | -82.43% | -67.02% |
| Cash from Financing | -- | 292.23% | 373.16% | 373.16% | 227.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 203.54% | 209.62% | 209.62% | 83.54% |